Sarcopenia is the progressive loss of muscle mass, strength, and function associated with aging. It starts earlier than you think and compromises your independence, metabolism, and ability to recover.
Sarcopenia is the progressive loss of muscle mass, strength, and function associated with aging. It starts earlier than you think — around age 30 — and accelerates after 60, compromising your independence, metabolism, and ability to recover from illness or injury.
Contrary to popular belief, sarcopenia is not just a problem for the very old. It is a silent process that advances over decades without obvious signs until, one day, getting up from a chair becomes an effort. The good news: it is one of the most modifiable age-related conditions with the tools we have available today.
What is sarcopenia and when does it start
The term "sarcopenia" (from the Greek sarx, flesh, and penia, loss) was coined in 1989 by Rosenberg to describe age-related muscle wasting. Today we know it goes far beyond losing volume — it is an integrated loss of mass, strength, and physical performance that affects the entire organism.
The rate of muscle loss is not constant. Between ages 30 and 50, you lose approximately 3-8% of muscle mass per decade. After 60, that rate doubles. And beyond 75, it can reach 15% per decade. Strength declines even faster than mass: up to 3-4% per year after age 70.
According to the review published in The Lancet by Cruz-Jentoft and Sayer (2019), sarcopenia is "a progressive and generalised skeletal muscle disorder involving the accelerated loss of muscle mass and function that is associated with increased adverse outcomes including falls, functional decline, frailty, and mortality." Global prevalence is estimated at 10% in people over 60, though that number varies widely depending on diagnostic criteria used.
What many people do not realize is that the process begins decades before symptoms become apparent. Research on the mechanisms of aging shows that sarcopenia results from the convergence of several of those mechanisms: mitochondrial dysfunction, cellular senescence, chronic inflammation, and altered nutrient signaling.
Symptoms and early warning signs
Sarcopenia does not announce itself with a dramatic event. It manifests through signals we tend to attribute to "getting older":
- Difficulty rising from a chair without using your hands — if you need to push off, your leg strength is already below where it should be
- Climbing stairs feels like more effort than it used to — loss of muscle power, not just mass
- Jars you used to open without thinking now require more effort — grip strength is one of the strongest predictors of longevity
- Fatigue during tasks that used to be routine — carrying groceries, walking briskly, playing with your children or grandchildren
- More stumbles or falls — loss of balance and strength feed each other in a downward spiral
- Unexplained weight loss — sometimes the scale misleads: you are not losing fat, you are losing muscle
A data point worth reflecting on: according to the PURE study (Leong et al., The Lancet, 2015), every 5 kg decrease in grip strength is associated with a 17% increase in all-cause mortality. Grip strength is a biomarker of aging as powerful as blood pressure or cholesterol, and is one of the key longevity biomarkers you should be monitoring.
How sarcopenia is diagnosed: the EWGSOP2 criteria
In 2019, the European Working Group on Sarcopenia in Older People (EWGSOP2) published a revised consensus establishing a clear, standardized diagnostic algorithm. This is the reference framework used in clinical practice across Spain and much of Europe.
The diagnostic process follows three steps:
Step 1: Screening with SARC-F. A 5-item questionnaire assessing strength, assistance with walking, ability to rise from a chair, climbing stairs, and history of falls. A score of ≥4 suggests sarcopenia risk and warrants deeper evaluation.
Step 2: Muscle strength assessment. If SARC-F is positive, strength is measured with handgrip dynamometry or the 5-time chair stand test.
Step 3: Confirmation with muscle mass and performance. If strength is low, confirmation comes from muscle mass measurements (DXA or bioimpedance) and physical performance (gait speed).
| Parameter | EWGSOP2 Cutoff | What it measures |
|---|---|---|
| Grip strength (dynamometry) | <27 kg men / <16 kg women | Muscle strength |
| 5-time chair stand test | >15 seconds | Functional strength |
| Appendicular lean mass (DXA) | <20 kg men / <15 kg women | Muscle quantity |
| Gait speed | ≤0.8 m/s | Physical performance |
| SARC-F (screening questionnaire) | ≥4 points | Sarcopenia risk |
Source: Cruz-Jentoft et al., "Sarcopenia: revised European consensus on definition and diagnosis", Age and Ageing 2019 (PMID: 30312372).
At Progevita, our functional assessment includes handgrip dynamometry, bioimpedance body composition, and physical performance tests — allowing us to detect sarcopenia in its early phases, when interventions are most effective.
Treatments with evidence: what actually works
The treatment landscape for sarcopenia has something unusual in longevity medicine: a solid, concrete evidence base. We are not talking about promising supplements with preliminary data. We are talking about interventions with decades of backing.
1. Progressive resistance training
This is, without question, the most effective intervention. A 2023 network meta-analysis examining 73 randomized controlled trials found that resistance exercise — alone or combined with nutrition — was the most effective intervention for improving quality of life, strength, and physical function in people with sarcopenia. Combining strength training with aerobic exercise and balance work produced the best overall results.
The protocol that makes a difference: 2-4 weekly sessions of progressive resistance training (free weights, machines, or bands), with loads that allow you to complete 8-12 reps with good form but where the last 2-3 genuinely challenge you. Progressively increasing the load over time is not optional — it is the signal your muscle needs to maintain itself and grow.
2. Adequate protein intake
The official recommendation of 0.8 g/kg/day is insufficient to preserve muscle with age. Current evidence points to 1.2-1.6 g of protein per kg of body weight per day for older adults, distributed across at least 3 meals with a minimum of 25-30 g of high-quality protein per meal. This efficiently activates muscle protein synthesis.
An evidence-based anti-inflammatory diet does not only help preserve muscle — it also reduces the chronic inflammation that accelerates its loss.
3. Creatine
Creatine monohydrate (3-5 g/day) has one of the strongest evidence profiles for improving strength and muscle mass in older adults, especially when combined with resistance training. It is not just for the gym: it also improves cognitive function and has an excellent safety profile.
4. Vitamin D (if deficient)
Low vitamin D levels are associated with worse muscle function and more falls. If your levels are below 30 ng/mL, supplementation improves strength and reduces fracture risk. If your levels are normal, the additional benefit is limited. As always in precision medicine: measure first, supplement after.
5. Sleep and daily activity
Poor sleep accelerates muscle loss by disrupting growth hormone, cortisol, and protein synthesis. And sedentary behavior — even in people who train for one hour a day — is an independent risk factor for muscle loss. Regular movement throughout the day (walking, stairs, household tasks) has a measurable protective effect on muscle mass.
What about drugs?
To date, there is no approved pharmacological treatment specifically for sarcopenia. Growth hormone secretagogues, selective androgen receptor modulators, and anti-myostatin agents have been investigated, but results have been disappointing or inconsistent. The current scientific consensus is clear: the first-line treatment is and remains resistance exercise combined with adequate nutrition.
The Primer published in Nature Reviews Disease Primers in 2024 (Sayer et al.) synthesizes this reality: sarcopenia management centers on lifestyle interventions, with pharmacology still far from offering a primary solution.
| Intervention | Evidence level | Recommendation |
|---|---|---|
| Progressive resistance training | High (meta-analyses, multiple RCTs) | First-line — 2-4 sessions/week |
| Protein 1.2-1.6 g/kg/day | High | Essential complement to exercise |
| Creatine 3-5 g/day | High (with exercise) | Add if no contraindications |
| Vitamin D (if deficient) | Moderate-High | Supplement if <30 ng/mL |
| Aerobic exercise + balance | Moderate | Combine with strength |
| Specific pharmacotherapy | Low (no approved drugs) | Not yet available |
Why sarcopenia accelerates aging
Muscle is not just a movement organ. It is the most metabolically active tissue in the body, a reservoir of amino acids, a glucose regulator, and a buffer against inflammation. When you lose muscle, you do not just lose strength — you lose systemic resilience.
Chronic low-grade inflammation (inflammaging) and sarcopenia feed each other: more visceral adipose tissue (which replaces lost muscle) produces pro-inflammatory cytokines that, in turn, accelerate cellular senescence and further muscle degradation. It is a vicious cycle.
The consequences are cumulative and serious:
- Fragility and falls: sarcopenia multiplies fall risk by 3-4x — falls are the leading cause of hospitalization and loss of independence in older adults
- Worse metabolism: less muscle means lower insulin sensitivity, higher diabetes type 2 risk, and worse lipid profile
- Poorer recovery: after surgery, infection, or hospitalization, recovery capacity depends heavily on available muscle reserve
- Greater dependence: severe sarcopenia is one of the strongest predictors of needing assistance with daily activities
- Reduced lung function: a 2026 meta-analysis in Archives of Gerontology and Geriatrics (Pan et al.) showed that sarcopenic patients have significantly reduced pulmonary function, and that resistance exercise is the most effective modality for improving it
Furthermore, sarcopenia is intimately linked to mitochondrial dysfunction: skeletal muscle mitochondria lose efficiency with age, producing less ATP and more free radicals, creating a cycle of oxidative damage and further muscle loss.
Prevention: start before it becomes urgent
The updated Asian Working Group for Sarcopenia (AWGS 2025) consensus, published in Nature Aging, introduced an important paradigm shift: expanding focus from diagnosis in older adults toward muscle health promotion across the entire lifespan. The new consensus recommends assessing muscle health starting at age 50, recognizing that early interventions are far more effective than late ones.
This changes the narrative. You do not need to wait until you are 70 to care about your muscle. Every decade that passes without adequate strength stimulus is mass and function you will not easily recover.
The prevention strategies with the strongest evidence:
- Strength training from your 30s-40s — not as an occasional hobby, but as a health pillar
- Sufficient protein at every meal — 25-30 g of complete protein, three times daily
- Stay active throughout the day — sedentary behavior is toxic to muscle, even if you train
- Check vitamin D and correct if needed — deficiency is more common than most people think
- Sleep 7-8 hours — most protein synthesis and growth hormone release occur during sleep
Gut health also plays a role: dysbiosis has been associated with poorer nutrient absorption and more systemic inflammation, both of which contribute to muscle loss. And epigenetic clocks allow you to measure whether your intervention is working at a biological level, not just on the scale.
What Progevita can do
At Progevita we approach sarcopenia as what it is: a functional longevity problem, not just a rehabilitation issue. Our approach integrates diagnosis, intervention, and follow-up:
- Complete functional assessment: handgrip dynamometry, bioimpedance body composition, VO₂max, and physical performance tests. Concrete data, not impressions.
- Personalized exercise plan: designed by trainers specialized in longevity, with individualized progression and supervision during your stay and beyond
- Tailored nutrition plan: consultation with a nutritionist to optimize protein, macro distribution, and supplementation (creatine, vitamin D, NAD+ where appropriate)
- Longitudinal follow-up: a 12-month plan with teleconsultations to adjust strategy based on your actual progress
All of this in a 200-hectare natural setting at Balneario de Cofrentes (Valencia), with volcanic thermal springs and a team of over 50 medical professionals.
If you want to know where your muscle stands and what you can do to protect it, book a functional assessment with our team.
Frequently asked questions
At what age does muscle loss begin?
Muscle mass starts declining around age 30, at a rate of 3-8% per decade. It accelerates after 60 and intensifies further after 75. Muscle strength declines even faster than mass: up to 3-4% per year after age 70.
Can sarcopenia be reversed?
Yes, at least partially. Progressive resistance training combined with adequate protein has been shown to increase muscle mass and strength even in people over 80. The earlier you start, the greater your muscle's capacity to respond. But it is never too late to benefit.
How much protein do I need to preserve muscle?
Current evidence recommends 1.2-1.6 g of protein per kg of body weight per day for older adults, distributed across at least 3 meals with 25-30 g of high-quality protein each. This exceeds the general recommendation of 0.8 g/kg/day, which is insufficient to counteract age-related muscle loss.
What exercises work best against sarcopenia?
Resistance (strength) training has the strongest evidence. Squats, deadlifts, presses, pull-downs — free weights or machines. What matters is that the load is progressive and the last few repetitions are genuinely challenging. Combining with balance and moderate cardio optimizes results.
How do I know if I have sarcopenia?
If you have difficulty rising from a chair without using your hands, climbing stairs requires more effort than before, or you notice decreased grip strength, you should get evaluated. A clinician can measure your strength with a dynamometer, your gait speed, and your body composition using EWGSOP2 criteria.
Do supplements help with sarcopenia?
Creatine (3-5 g/day) and vitamin D (if deficient) have the best evidence. Creatine enhances the effects of resistance exercise, and vitamin D improves muscle function when levels are low. No supplement replaces resistance training and adequate protein intake.
Is sarcopenia the same as frailty?
No, though they are related. Frailty is a broader clinical syndrome that includes vulnerability to stressors (illness, surgery, trauma). Sarcopenia is one of the main components of frailty, but you can have sarcopenia without being frail, and you can be frail without severe sarcopenia.
References
- Cruz-Jentoft AJ, Sayer AA. "Sarcopenia." The Lancet. 2019;393(10191):2636-2646. PMID: 31171417.
- Cruz-Jentoft AJ, Bahat G, Bauer J, et al. "Sarcopenia: revised European consensus on definition and diagnosis." Age and Ageing. 2019;48(1):16-31. PMID: 30312372.
- Sayer AA, Cruz-Jentoft AJ, et al. "Sarcopenia." Nature Reviews Disease Primers. 2024;10:68. DOI: 10.1038/s41572-024-00559-1.
- Chen LK, et al. "A focus shift from sarcopenia to muscle health in the Asian Working Group for Sarcopenia 2025 Consensus Update." Nature Aging. 2025. PMID: 41188603.
- Pan J, Chen L, Xu T, He Y, Hu X. "Effects of different exercise modalities on pulmonary function in older patients with sarcopenia: A systematic review and meta-analysis." Archives of Gerontology and Geriatrics. 2026;145:106204. PMID: 41861568.
- Leong DP, et al. "Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study." The Lancet. 2015;386(9990):266-273. PMID: 25982160.
- Lopez-Otin C, et al. "Hallmarks of aging: An expanding universe." Cell. 2023;186(2):243-278. PMID: 36599349.
- "Effectiveness of different types of exercise based-interventions in sarcopenia: A systematic review and meta-analysis." Ageing Research Reviews. 2025. DOI: 10.1016/j.arr.2025.102576.